Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Americans are willing to use mobile devices to let physicians track their health, according to a new report from PricewaterhouseCoopers.
Medical News Today recently published a round-up of studies related to the efficacy of health information technology.
Copyright © 2024 | WordPress Theme by MH Themes